VEGFR-2 AND VEGFR-3 INHIBITORY ANTHRANYLAMIDE PYRIDINE

PROBLEM TO BE SOLVED: To provide a VEGFR-2 and VEGFR-3 inhibitory anthranylamide pyridinamide, a method of formation and use of the same as a medicine for the treatment of a disease caused by persisting vasculogenesis and an intermediate for the formation of the compound. SOLUTION: This compound can...

Full description

Saved in:
Bibliographic Details
Main Authors HABEREY MARTIN, HUTH ANDREAS, ZORN LUDWIG, THIERAUCH KARL-HEINZ, KRUEGER MARTIN, INCE STUART, HESS-STUMP HOLGER, MENRAD ANDREAS
Format Patent
LanguageEnglish
Published 10.02.2011
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:PROBLEM TO BE SOLVED: To provide a VEGFR-2 and VEGFR-3 inhibitory anthranylamide pyridinamide, a method of formation and use of the same as a medicine for the treatment of a disease caused by persisting vasculogenesis and an intermediate for the formation of the compound. SOLUTION: This compound can be used for the treatment of, for example, tumor or metastatic growth, psoriasis, Kaposi sarcoma, restenosis, for example, stent-induced restenosis, endometriosis, Crohn's disease, Hodgkin's disease, leukemia; arthritis, for example, rheumatoid arthritis, vascular neoplasm, angiofibroma, eye disease, renal disease, fibrotic disease, arterial sclerosis, etc. COPYRIGHT: (C)2011,JPO&INPIT
Bibliography:Application Number: JP20100233026